These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8082410)

  • 1. Post-antibiotic effects of cefdinir on Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus and Streptococcus pyrogenes.
    Howard BM; Pinney RJ; Smith JT
    Chemotherapy; 1994; 40(4):232-8. PubMed ID: 8082410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contributions of post-antibiotic lag and repair-recovery to the post-antibiotic effects of ciprofloxacin on Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus and Streptococcus pyogenes.
    Howard BM; Pinney RJ; Smith JT
    Chemotherapy; 1993; 39(1):22-31. PubMed ID: 8444058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-antibiotic effects of ofloxacin on Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus, and Streptococcus pyogenes.
    Howard BM; Pinney RJ; Smith JT
    Chemotherapy; 1993; 39(4):265-71. PubMed ID: 8325128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological alterations of Staphylococcus aureus and Streptococcus pyogenes exposed to cefdinir, a new oral broad-spectrum cephalosporin.
    Hatano K; Nishino T
    Chemotherapy; 1994; 40(2):73-9. PubMed ID: 8131637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro activity of cephalosporins.
    Stewart D; Bodey GP
    J Antibiot (Tokyo); 1976 Feb; 29(2):181-6. PubMed ID: 6411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
    Odenholt I; Cars O
    J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-acyloxymethyl-7-(2-thienylacetamido)-3-cephem-4-carboxylic acids. An improved synthesis and biological properties.
    Berges DA
    J Med Chem; 1975 Dec; 18(12):1264-5. PubMed ID: 811800
    [No Abstract]   [Full Text] [Related]  

  • 8. [New cephalosporin antibiotic: cephapirin].
    Urbinati G
    Clin Ter; 1977 Mar; 80(5):491-9. PubMed ID: 322931
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on the antimicrobial effect of vitamin D (author's transl)].
    Feindt E; Ströder J
    Klin Wochenschr; 1977 May; 55(10):507-8. PubMed ID: 195120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of High N-Acetylcysteine Concentrations on Antibiotic Activity against a Large Collection of Respiratory Pathogens.
    Landini G; Di Maggio T; Sergio F; Docquier JD; Rossolini GM; Pallecchi L
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7513-7517. PubMed ID: 27736757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial studies in vitro with cephacetrile, a new cephalosporin derivative.
    Knüsel F; Konopka EA; Gelzer J; Rosselet A
    Arzneimittelforschung; 1974 Sep; 24(9b):1451-5. PubMed ID: 4215433
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral antibiotics for infections due to multidrug-resistant Gram-negative organisms.
    Glasser JS; Markelz AE; Zera WC; Beckius ML; Mende K; Murray CK
    Scand J Infect Dis; 2011 Aug; 43(8):649-51. PubMed ID: 21466257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MICy: a Novel Flow Cytometric Method for Rapid Determination of Minimal Inhibitory Concentration.
    Kállai A; Kelemen M; Molnár N; Tropotei A; Hauser B; Iványi Z; Gál J; Ligeti E; Kristóf K; Lőrincz ÁM
    Microbiol Spectr; 2021 Dec; 9(3):e0090121. PubMed ID: 34878335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of cephapirin and related cephalosporins from 7-(alpha-bromoacetamido)cephalosporanic acid.
    Crast LB; Graham RG; Cheney LC
    J Med Chem; 1973 Dec; 16(12):1413-5. PubMed ID: 4148798
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel cephalosporins. Modification of the C-4 carboxyl group.
    Jen T; Dienel B; Frazee J; Weisbach J
    J Med Chem; 1972 Nov; 15(11):1172-4. PubMed ID: 4631921
    [No Abstract]   [Full Text] [Related]  

  • 16. Laboratory studies with BL-S 578 (Cefadroxil) a new broad-spectrum orally active cephalosporin.
    Ripa S; Prenna M
    Chemotherapy; 1979; 25(1):9-13. PubMed ID: 33784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of cefdinir (FK482) and ten other antibiotics against gram-positive and gram-negative bacteria isolated from adult and pediatric patients.
    Sultan T; Baltch AL; Smith RP; Ritz W
    Chemotherapy; 1994; 40(2):80-91. PubMed ID: 8131638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bactericidal effect of combinations of cephalosporins with tobramycin on clinical isolates of Escherichia coli, Klebsiella and Staphylococcus aureus.
    Wagenvoort JH; Brus-Weijer L; Michel MF
    Arzneimittelforschung; 1986 Sep; 36(9):1301-2. PubMed ID: 3539124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo postantibiotic effect in a thigh infection in neutropenic mice.
    Vogelman B; Gudmundsson S; Turnidge J; Leggett J; Craig WA
    J Infect Dis; 1988 Feb; 157(2):287-98. PubMed ID: 3121761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simocyclinone D8 turns on against Gram-negative bacteria in a clinical setting.
    Richter SN; Frasson I; Palumbo M; Sissi C; Palù G
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1202-4. PubMed ID: 20022496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.